Author pages are created from data sourced from our academic publisher partnerships and public sources.
Energy expenditure during front crawl swimming: predicting success in middle-distance events.
- D. Costill, J. Kovaleski, D. Porter, J. Kirwan, R. Fielding, D. King
- International journal of sports medicine
- 1 October 1985
Male (n = 25) and female (n = 14) competitive swimmers were studied during tethered (breaststroke) and free (front crawl) swimming to determine the validity of calculating exercise oxygen uptake… Expand
Profile of cognitive functioning in women with the fragile X mutation.
- L. Bennetto, B. Pennington, D. Porter, A. K. Taylor, R. Hagerman
- Medicine, Psychology
- 1 April 2001
Two studies tested the specificity of the neurocognitive profile of women with fragile X syndrome (FXS). First, women with an FXS full mutation were compared with women with a premutation and women… Expand
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
- G. Burmester, M. Weinblatt, +11 authors F. Magrini
- Annals of the rheumatic diseases
- 12 December 2012
Objectives Mavrilimumab, a human monoclonal antibody targeting the alpha subunit of the granulocyte-macrophage colony-stimulating factor receptor, was evaluated in a phase 2 randomised, double-blind,… Expand
Emotional and neurocognitive deficits in fragile X.
- W. Sobesky, B. Pennington, D. Porter, C. Hull, R. Hagerman
- Biology, Medicine
- American journal of medical genetics
- 15 July 1994
We have studied the neurocognitive deficit in premutation and full mutation women as compared to control women and to explore the relationship between those deficits and the incidence of emotional… Expand
Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial
Objective To investigate whether an intensive early rheumatoid arthritis (RA) treat-to-target (T2T) strategy could be improved through the use of musculoskeletal ultrasound (MSUS) assessment of… Expand
Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial.
BACKGROUND Evidence for disease modifying activity of low dose corticosteroid treatment in rheumatoid arthritis is contradictory. Studies showing radiological benefit suggest that continued treatment… Expand
Late Ebola virus relapse causing meningoencephalitis: a case report
Summary Background There are thousands of survivors of the 2014 Ebola outbreak in west Africa. Ebola virus can persist in survivors for months in immune-privileged sites; however, viral relapse… Expand
UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug.
OBJECTIVE To evaluate the incremental cost effectiveness of rituximab in patients with rheumatoid arthritis that failed to respond adequately to tumour necrosis factor-alpha inhibitors (biologic… Expand
Tightening Up? Impact of Musculoskeletal Ultrasound Disease Activity Assessment on Early Rheumatoid Arthritis Patients Treated Using a Treat to Target Strategy
- J. Dale, D. Purves, A. McConnachie, I. McInnes, D. Porter
- Arthritis care & research
- 1 January 2014
To determine the level of agreement and potential impact on disease‐modifying antirheumatic drug (DMARD) escalation decisions and of adding musculoskeletal ultrasound (MSUS) assessment of disease… Expand
Pharmacotherapy: concepts of pathogenesis and emerging treatments. Optimising the strategy of care in early rheumatoid arthritis.
In rheumatoid arthritis (RA), early use of disease-modifying anti-rheumatic drugs (DMARDs), intensive follow-up and 'treating to target' to achieve low disease activity produce significant… Expand